A Novel RNA In Situ Hybridization Assay for the Long Noncoding RNA SChLAP1 Predicts Poor Clinical Outcome After Radical Prostatectomy in Clinically Localized Prostate Cancer()()

Eitemau Tebyg

• A Novel RNA In Situ Hybridization Assay for the Long Noncoding RNA SChLAP1 Predicts Poor Clinical Outcome After Radical Prostatectomy in Clinically Localized Prostate Cancer
  gan: Rohit Mehra, et al.
  Cyhoeddwyd: (2014-12-01)
• The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex
  gan: Prensner, John R., et al.
  Cyhoeddwyd: (2013)
• Overexpression of the Long Non-coding RNA SChLAP1 Independently Predicts Lethal Prostate Cancer
  gan: Mehra, Rohit, et al.
  Cyhoeddwyd: (2015)
• Nomination and validation of the long noncoding RNA SChLAP1 as a risk factor for metastatic prostate cancer progression: a multi-institutional high-throughput analysis
  gan: Prensner, John R., et al.
  Cyhoeddwyd: (2014)
• Long Noncoding RNA SChLAP1 Accelerates the Proliferation and Metastasis of Prostate Cancer via Targeting miR-198 and Promoting the MAPK1 Pathway
  gan: Li, Ye, et al.
  Cyhoeddwyd: (2018)